HIGHLIGHTS
- who: Tali Azenkot and Brian A. Jonas from the Department of Internal Medicine, University of California Davis School of Medicine, Medicine, University of California Davis School of Medicine, Sacramento, CA, USA have published the research: Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia, in the Journal: Cancers 2022, 14, 3634. of /2022/
- future: More prospective randomized studies are needed to guide the application of MRD in the treatment of AML particularly in transplant.
SUMMARY
In response to advances in MRD detection, quantification, and application in patient care, ELN and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.